心脏重塑的评估——新型心脏生物标志物的契机？
Assessment of Cardiac Remodeling-A Chance for Novel Cardiac Biomarkers?
作者信息
Jirak Peter, Mirna Moritz, Wernly Bernhard, Paar Vera, Hoppe Uta C, Lichtenauer Michael
机构信息
Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
出版信息
J Clin Med. 2020 Jul 3;9(7):2087. doi: 10.3390/jcm9072087.
Abstract
Biomarkers are defined as "cellular, biochemical or molecular alterations that are measurable in biological media such as human tissues, cells, or fluids", providing "biological characteristics that can be objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention "according to Hulka et al [...].
摘要
生物标志物被定义为“可在生物介质（如人体组织、细胞或体液）中测量的细胞、生化或分子改变”，根据胡尔卡等人[……]的说法，它提供“可客观测量和评估的生物学特征，作为正常生物学过程、致病过程或对治疗干预的药理反应的指标”。
相似文献
1
Assessment of Cardiac Remodeling-A Chance for Novel Cardiac Biomarkers?心脏重塑的评估——新型心脏生物标志物的契机？
J Clin Med. 2020 Jul 3;9(7):2087. doi: 10.3390/jcm9072087.
4
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].[ANMCO/ELAS/SIBioC共识文件：心力衰竭患者心脏生物标志物使用建议]
G Ital Cardiol (Rome). 2016 Sep;17(9):615-656. doi: 10.1714/2448.25658.
5
How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease.生物标志物操作指南：生物标志物的定义、验证和应用，附有心血管疾病的实例。
Postgrad Med J. 2009 Oct;85(1008):538-45. doi: 10.1136/pgmj.2008.073759.
6
[Biomarkers and pharmacokinetic-pharmacodynamic studies of immunosuppressive agents].[免疫抑制剂的生物标志物及药代动力学-药效学研究]
Therapie. 2004 Mar-Apr;59(2):179-83. doi: 10.2515/therapie:2004034.
7
Measuring Biomarker Progress.测量生物标志物进展。
Clin Pharmacol Ther. 2015 Jul;98(1):2-5. doi: 10.1002/cpt.133.
9
Phenotyping and Endotyping Asthma Based on Biomarkers.基于生物标志物的哮喘表型分析与内型分析
Curr Top Med Chem. 2016;16(14):1582-6. doi: 10.2174/1568026616666150930120803.
10
Biomarkers for Hepatocellular Carcinoma (HCC): An Update.肝细胞癌（HCC）的生物标志物：最新进展
Adv Exp Med Biol. 2015;867:179-93. doi: 10.1007/978-94-017-7215-0_12.
引用本文的文献
1
Soluble ST2 as a Biomarker for Predicting Right Ventricular Dysfunction in Acute Pulmonary Embolism.可溶性ST2作为预测急性肺栓塞右心室功能障碍的生物标志物。
J Clin Med. 2024 Nov 27;13(23):7211. doi: 10.3390/jcm13237211.
本文引用的文献
1
Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls.与缺血性心肌病（ICM）、扩张型心肌病（DCM）及对照组相比，射血分数保留的心力衰竭（HFpEF）患者新型心脏生物标志物可溶性ST2（sST2）、生长分化因子15（GDF-15）、可溶性尿激酶型纤溶酶原激活物受体（suPAR）和心脏型脂肪酸结合蛋白（H-FABP）的表达情况
J Clin Med. 2020 Apr 15;9(4):1130. doi: 10.3390/jcm9041130.
2
Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction.联合新型生物标志物对ST段抬高型心肌梗死患者两年心血管死亡率进行风险分层
J Clin Med. 2020 Feb 18;9(2):550. doi: 10.3390/jcm9020550.
3
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week.心力衰竭中 sST2 的临床和预后意义：JACC 本周综述专题。
J Am Coll Cardiol. 2019 Oct 29;74(17):2193-2203. doi: 10.1016/j.jacc.2019.08.1039.
4
Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).肺动脉高压（PH）患者新型心血管生物标志物分析。
Heart Lung Circ. 2020 Mar;29(3):337-344. doi: 10.1016/j.hlc.2019.03.004. Epub 2019 Apr 1.
5
Mechanisms of physiological and pathological cardiac hypertrophy.生理性和病理性心肌肥厚的机制。
Nat Rev Cardiol. 2018 Jul;15(7):387-407. doi: 10.1038/s41569-018-0007-y.
6
Analysis of novel cardiovascular biomarkers in patients with peripheral artery disease.外周动脉疾病患者新型心血管生物标志物分析。
Minerva Med. 2018 Dec;109(6):443-450. doi: 10.23736/S0026-4806.18.05628-8. Epub 2018 Apr 12.
7
Redefining biomarkers in heart failure.重新定义心力衰竭的生物标志物。
Heart Fail Rev. 2018 Mar;23(2):237-253. doi: 10.1007/s10741-018-9683-2.
8
Extracellular matrix remodeling and cardiac fibrosis.细胞外基质重构与心脏纤维化。
Matrix Biol. 2018 Aug;68-69:490-506. doi: 10.1016/j.matbio.2018.01.013. Epub 2018 Jan 31.
9
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.白细胞介素-33（IL-33）：IL-1 家族的一种核细胞因子。
Immunol Rev. 2018 Jan;281(1):154-168. doi: 10.1111/imr.12619.
10
Soluble ST2 in Heart Failure.心力衰竭中的可溶性ST2
Heart Fail Clin. 2018 Jan;14(1):41-48. doi: 10.1016/j.hfc.2017.08.005.
Zotero 插件